Medicare and Medicaid programs; hospital conditions of participation: laboratory services. Final rule.
This final rule finalizes the hospital conditions of participation requirements for hospitals that transfuse blood and blood components. It requires hospitals to: Prepare and follow written procedures for appropriate action when it is determined that blood and blood components the hospitals received and transfused are at increased risk for transmitting hepatitis C virus (HCV); quarantine prior collections from a donor who is at increased risk for transmitting HCV infection; notify transfusion recipients, as appropriate, of the need for HCV testing and counseling; and extend the records retention period for transfusion-related data to 10 years. The intent is to aid in the prevention of HCV infection and to create opportunities for disease prevention that, in most cases, can occur many years after recipient exposure to a donor.
D001782:Blood Donors / Q000331:legislation & jurisprudence*; D001803:Blood Transfusion / Q000331:legislation & jurisprudence* / Q000592:standards; D006526:Hepatitis C / Q000635:transmission; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000331:legislation & jurisprudence*; D007755:Laboratories, Hospital / Q000331:legislation & jurisprudence*; D007882:Legislation, Hospital; D006278:Medicare / Q000331:legislation & jurisprudence*; D015442:Medicare Assignment / Q000331:legislation & jurisprudence*; D013997:Time Factors; D014481:United States